ARTICLE | Company News
Atrix, EmerGen deal
November 11, 2002 8:00 AM UTC
ATRX granted EmerGen exclusive North American development and marketing rights to ATRX’s one- and three-month formulations of leuprolide to treat endometriosis. The compounds are in preclinical testin...